By 2028, the pharmaceutical CDMO market is projected to grow at a CAGR of 6.74% and reach $309.5 billion. They stand to be the best partners to help the industry adapt to new trends such as small molecule drugs and personalized medicine. The future is promising for CDMOs!
You can read the full report here: https://lnkd.in/eSd_wX2Q
#cdmo #medicines #pharmaceutical #manufacturing #lannettcdmo
Like
Comment
Share
